# Thymogen — dosage, half-life & reference guide | PepVault

Source: https://pepvault.app/peptides/thymogen

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Healing & recovery](https://pepvault.app/peptides#healing)

# Thymogen Dosage, half-life & reference guide

Also known as Timogen · Glu-Trp · EW dipeptide · L-glutamyl-L-tryptophan · IM862

Reviewed November 2026 2 studies Evidence: Emerging [Published by PepVault](https://pepvault.app/guides/how-we-research)

A two-amino-acid peptide (Glu-Trp) from the Russian bioregulator program, isolated from the thymus extract Thymalin and used as an immune drug. In mice it slowed tumors through natural killer cells, and in a Russian placebo-controlled study it cut complications after cancer surgery in older patients; tested in the US as IM862, it did no better than placebo against Kaposi sarcoma.

- **How often:** Daily
- **Half-life:** Unknown
- **Evidence:** Emerging
- **Routes:** SubQ, Nasal spray +1

No study has set a dose of Thymogen for the uses people run it for: the amounts people run are their own protocol, not a reference.

## How it works.

A dipeptide, Glu-Trp (EW), that Vladimir Khavinson's St. Petersburg group isolated from their calf-thymus extract Thymalin and developed into an immune drug. In mice, a US team found it slowed tumors only when natural killer cells were present, so it works through the immune system rather than on tumor cells directly. In rats injected for a year, the longest-lived tenth lived longer and tumors were fewer. In people, a Russian placebo-controlled study before abdominal cancer surgery reported fewer complications; tested independently in the US as IM862, it did no better than placebo against Kaposi sarcoma in a phase 3 trial of 202 people.

**Commonly reported:** Little to feel during a short course; some soreness where it goes in.

<!--promo-->

PepVault for iPhone

## Track thymogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where Thymogen works.

- ### Immune system

  **In animals.** In mice, a US team found it slowed tumors only when natural killer cells were present, so it works through the immune system rather than on tumor cells directly.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

## Week by week.

What to expect in the first 8 weeks

- **Onset:** Not established (no controlled timing data)
- **Peak effect:** Not established
- **Duration:** Courses of 3–10 days (community practice)

1. Day 1–7 Community

   ### A week-long course

   Thymogen is used in short courses; the Russian study gave it once a day for 7 days. Commonly reported: little to feel during the course, with some soreness where it goes in, or a sneeze or two with the spray.

   Updated Nov 2026
2. Day 7–30 RCT

   ### What the surgery study measured

   In a Russian placebo-controlled study, older patients given Thymogen for a week before abdominal cancer surgery had fewer complications afterward and shorter recoveries. It is the strongest result for the drug in its own country, and one study.

   The science

   Smirnov 2011: a double-blind, randomized, placebo-controlled study in elderly patients before surgery for solid abdominal and retroperitoneal tumors, intranasal once daily for 7 days against saline; cellular immunity measures recovered and postoperative complications fell. The abstract gives no group sizes.

   Sources

   - Smirnov et al. (2011)

   Updated Nov 2026
3. Day 30–180 RCT

   ### The independent trials said no

   Thymogen's molecule is the only bioregulator taken through independent trials. As IM862 it did no better than placebo against Kaposi sarcoma in 202 people, and shrank no tumors in kidney cancer. Those trials tested cancer, not the immune uses people run it for.

   The science

   Noy 2005: 24-week randomized, double-blind, placebo-controlled phase 3, 104 on IM862 and 98 on placebo; response 23% against 21%, and a shorter median time to progression on IM862 (16 against 35 weeks). Deplanque 2004: phase 2 in metastatic renal cell carcinoma, 25 patients, no grade 2 or 3 toxicity from the drug, no significant objective responses, lower VEGF.

   Sources

   - Noy et al. (2005)
   - Deplanque et al. (2004)

   Updated Nov 2026
4. Any day RCT

   ### What Thymogen is built on

   A two-amino-acid peptide isolated from the thymus extract Thymalin. In rodents it acts through natural killer cells and slowed tumors; in people, one Russian controlled study is positive and two independent cancer trials of the same molecule were not.

   The science

   Anisimov 2000: Glu-Trp isolated from Thymalin, developed as Thymogen; in 76 female rats injected 5 times a week for 12 months, mean lifespan was unchanged, the longest-lived tenth lived 1,048 against 949 days, and total tumors were 1.5 times and malignant ones 1.7 times less common. Smith 2003 (USC): in mice its anti-tumor effect required NK cells and perforin and was partly IL-12-dependent. People: Smirnov 2011; Noy 2005; Deplanque 2004.

   Sources

   - Anisimov et al. (2000)
   - Smith et al. (2003)
   - Smirnov et al. (2011)
   - Noy et al. (2005)
   - Deplanque et al. (2004)

   Updated Nov 2026
5. With Thymalin Community

   ### The extract it came from

   Thymogen is one of the active parts of Thymalin, and in Russian practice the two are sometimes used together for immune support. No study has tested the pair.

   The science

   Glu-Trp (EW) and Lys-Glu (KE) are active substances of Thymalin (Linkova 2023); Glu-Trp was isolated from it and developed as Thymogen (Anisimov 2000). The pairing is community and protocol practice.

   Sources

   - Linkova et al. (2023)
   - Anisimov et al. (2000)

   Updated Nov 2026

Day 1 is the day you start it.

The human data are one Russian placebo-controlled study and two independent cancer trials of the same molecule, which did not show a benefit. The mechanism comes from mouse and rat studies.

Preliminary research

## More on thymogen

### Studies

- [Thymogen (IM862): 36% major responses in AIDS-related Kaposi's sarcoma](https://pepvault.app/research/thymogen-tulpule-2000)
- [Thymogen (IM862): 8 of 25 kidney cancer patients had stable disease](https://pepvault.app/research/thymogen-deplanque-2004)
- [All 2 studies](https://pepvault.app/research#thymogen)

### Compared with

- [Thymalin vs Thymogen](https://pepvault.app/peptides/compare/thymalin-vs-thymogen)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

## A typical run.

### Run notes

- **Cycle:** Run in short courses rather than continuously: the Russian surgical study gave it for 7 days, and community courses run 3–10 days. No study has tested a course length for general use. Community practice — opinions vary. Not a clinical recommendation.
- **Timing:** No timing has been studied. As a nasal drug it was given once a day in the Russian study.
- **Routes:** SubQ injection, Nasal spray, IM injection
- **Stacks:** Thymalin

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-mixing&mt=8)

<!--/promo-->

## Safety.

### Common side effects

- Injection-site redness or soreness
- Nasal irritation or sneezing (spray)

#### Interactions

No interaction studies exist. It acts on the immune system, so immune-suppressing medicines and other immune peptides are worth raising with your clinician.

### Safety notes

In its trials the side effects were mild: a UK phase 2 trial of 25 people recorded no moderate or severe side effect from the drug. In the US phase 3 trial against Kaposi sarcoma, the disease progressed sooner in the IM862 group than on placebo (a median of 16 against 35 weeks), a finding in that cancer only. Discuss with your clinician before use, particularly during pregnancy or breastfeeding, with an autoimmune condition or cancer, or alongside medicines that act on the immune system.

## Goes with.

- [Thymalin](https://pepvault.app/peptides/thymalin)

## One question at a time.

- [Side effects](https://pepvault.app/peptides/thymogen/side-effects)
- [How long it takes to work](https://pepvault.app/peptides/thymogen/how-long-to-work)
- [Legal status](https://pepvault.app/peptides/thymogen/legal-status)
- [The bioregulator family](https://pepvault.app/bioregulators)

## Compared with.

- [Thymalin vs Thymogen](https://pepvault.app/peptides/compare/thymalin-vs-thymogen)

## Studies, in plain English.

- [Thymogen (IM862): 36% major responses in AIDS-related Kaposi's sarcoma](https://pepvault.app/research/thymogen-tulpule-2000)
- [Thymogen (IM862): 8 of 25 kidney cancer patients had stable disease](https://pepvault.app/research/thymogen-deplanque-2004)
- [Every study on Thymogen](https://pepvault.app/research#thymogen)

## Questions people ask.

### What is Thymogen?

A two-amino-acid peptide (Glu-Trp) from the Russian bioregulator program, isolated from the thymus extract Thymalin and used as an immune drug. In mice it slowed tumors through natural killer cells, and in a Russian placebo-controlled study it cut complications after cancer surgery in older patients; tested in the US as IM862, it did no better than placebo against Kaposi sarcoma.

### How is Thymogen dosed in research?

The library carries no reference dose for Thymogen. No study has set a dose of Thymogen for the uses people run it for: the amounts people run are their own protocol, not a reference.

### How long does Thymogen last?

The half-life of Thymogen is unknown (never measured in people).

### What do people report on Thymogen?

Commonly reported on Thymogen: little to feel during a short course; some soreness where it goes in.

### Is Thymogen safe?

The research basis for Thymogen is emerging: primarily preclinical / limited human data. Common side effects in the library: injection-site redness or soreness and nasal irritation or sneezing (spray).

### What does Thymogen stack with?

Common stacks for Thymogen: Thymalin.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-questions&mt=8)

<!--/promo-->

## Research.

The literature

### Search the latest research

[PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=Thymogen) [Google Scholar](https://scholar.google.com/scholar?q=Thymogen)

## Reference.

- **Cadence:** Daily
- **Half-life:** Unknown Unknown (never measured in people)
- **Research basis:** Emerging Primarily preclinical / limited human data

## More healing & recovery peptides

- [Vilon No reference dose](https://pepvault.app/peptides/vilon)
- [Thymosin Beta-4 2–2.5 mg](https://pepvault.app/peptides/thymosin-beta-4)
- [LL-37 100–300 mcg](https://pepvault.app/peptides/ll-37)
- [Larazotide 0.5–1 mg](https://pepvault.app/peptides/larazotide)
- [Linaclotide 72–290 mcg](https://pepvault.app/peptides/linaclotide)
- [VIP 50 mcg](https://pepvault.app/peptides/vip)

## Free tools

- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Track thymogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track thymogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on thymogen

### Studies

- [Thymogen (IM862): 36% major responses in AIDS-related Kaposi's sarcoma](https://pepvault.app/research/thymogen-tulpule-2000)
- [Thymogen (IM862): 8 of 25 kidney cancer patients had stable disease](https://pepvault.app/research/thymogen-deplanque-2004)
- [All 2 studies](https://pepvault.app/research#thymogen)

### Compared with

- [Thymalin vs Thymogen](https://pepvault.app/peptides/compare/thymalin-vs-thymogen)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Intramuscular (IM)](https://pepvault.app/glossary/intramuscular)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

<!--promo-->

PepVault for iPhone

## Track thymogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
